|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Oregon Health and Science University Cancer Institute National Cancer Institute (NCI) |
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00244894 |
Purpose
RATIONALE: Acupuncture may help relieve hot flashes in patients with prostate cancer.
PURPOSE: This clinical trial is studying how well acupuncture works in treating hot flashes in patients with prostate cancer who are undergoing androgen deprivation.
| Condition | Intervention |
|
Fatigue Hot Flashes Prostate Cancer |
Procedure: acupuncture therapy Procedure: fatigue assessment and management Procedure: hot flashes attenuation Procedure: management of therapy complications Procedure: quality-of-life assessment |
| MedlinePlus related topics: | Acupuncture Cancer Prostate Cancer |
| Study Type: | Interventional |
| Study Design: | Supportive Care, Open Label |
| Official Title: | Acupuncture for Hot Flashes in Prostate Cancer Patients |
| Estimated Enrollment: | 25 |
| Study Start Date: | September 2002 |
| Primary Completion Date: | December 2007 (Final data collection date for primary outcome measure) |
OBJECTIVES:
OUTLINE: Patients undergo acupuncture for 30 minutes twice weekly for 4 weeks and then once weekly for an additional 6 weeks.
Quality of life is assessed at baseline, at weeks 2, 4, 6, and 10, and then at 6 weeks after completion of study treatment.
After completion of study treatment, patients are followed at 6 weeks.
PROJECTED ACCRUAL: A total of 25 patients will be accrued for this study.
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Prior or concurrent treatment with 1 of the following :
PATIENT CHARACTERISTICS:
Performance status
Life expectancy
Hematopoietic
Hepatic
Renal
Other
PRIOR CONCURRENT THERAPY:
Chemotherapy
Endocrine therapy
Surgery
Other
Contacts and Locations| United States, Oregon | |||||
| Oregon Health & Science University Cancer Institute | |||||
| Portland, Oregon, United States, 97239-3098 | |||||
| Oregon Health and Science University Cancer Institute |
| National Cancer Institute (NCI) |
| Principal Investigator: | Tomasz M. Beer, MD | Oregon Health and Science University Cancer Institute |
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database 
  |
| Study ID Numbers: | CDR0000445180, OHSU-7235, OHSU-HOR-02029-LX |
| First Received: | October 25, 2005 |
| Last Updated: | March 17, 2008 |
| ClinicalTrials.gov Identifier: | NCT00244894 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|